Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran
about
Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran.Priority Setting for Improvement of Cervical Cancer Prevention in IranCost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran.Cervical cancer in Iran: integrative insights of epidemiological analysis
P2860
Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-Effectiveness Evaluation ...... or HPV-Related Disease in Iran
@en
Cost-Effectiveness Evaluation ...... r HPV-Related Disease in Iran.
@nl
type
label
Cost-Effectiveness Evaluation ...... or HPV-Related Disease in Iran
@en
Cost-Effectiveness Evaluation ...... r HPV-Related Disease in Iran.
@nl
prefLabel
Cost-Effectiveness Evaluation ...... or HPV-Related Disease in Iran
@en
Cost-Effectiveness Evaluation ...... r HPV-Related Disease in Iran.
@nl
P2093
P2860
P1476
Cost-Effectiveness Evaluation ...... or HPV-Related Disease in Iran
@en
P2093
Hamid Reza Jamshidi
Hamid Reza Rasekh
Mohsen Khatibi
Zohreh Shahverdi
P2860
P304
P577
2014-01-01T00:00:00Z